Harpreet S Bajaj, Michelle Welch, Parag Shah, Eduardo Luna, Fatima-Zahra Jaouimaa, Bing Liu, Rong Liu, Yanyun Chen, Hiren Patel, Amy Bartee
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 45
- Comments 0
Advertisement
[Articles] Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
Journal content Created on 06 Jun 2026 The Lancet
Advertisement